Target intelligence / Profile preview

A-kinase anchoring protein 1 (AKAP1)

Target
AKAP1
Molecular classification
Scaffold protein, Mitochondria-associated protein, Other
01

Overview

A-kinase anchoring protein 1 (AKAP1) is a mitochondrial scaffold protein that anchors protein kinase A (PKA) and other signaling proteins to the outer mitochondrial membrane, orchestrating localized signal transduction events[2][4]. It plays a critical role in regulating mitochondrial dynamics by inhibiting fission and promoting fusion, thereby maintaining mitochondrial integrity and function[1][4]. AKAP1 modulates oxidative phosphorylation and ATP production, buffers mitochondrial calcium, reduces reactive oxygen species (ROS), and prevents apoptosis in stressed cells, conferring cardioprotective and neuroprotective effects[1][2][4]. AKAP1 is implicated in the regulation of pathological cardiac hypertrophy, heart failure, neurodegenerative diseases, and cancer, acting largely by controlling mitochondrial homeostasis and cell survival signaling. Loss or downregulation of AKAP1 leads to enhanced mitochondrial fragmentation, oxidative stress, and cell death, particularly in cardiomyocytes and neurons[1][2][4]. There are currently no approved drugs specifically targeting AKAP1, but its central role in disease pathways makes it a potential therapeutic target[2].

Other names
D-AKAP1AKAP121AKAP149
02

Biological functions

Signal transductionRegulation of mitochondrial dynamics (fission and fusion)Regulation of oxidative phosphorylationRegulation of apoptosisMaintenance of mitochondrial integrityRegulation of cardiomyocyte hypertrophyCellular stress response
03

Disease associations

Cardiovascular disease (including cardiac hypertrophy, heart failure)Neurodegenerative diseaseCancerMetabolic diseaseOther
04

Safety considerations

Potential impact on mitochondrial function and cellular energy metabolism if dysregulatedPossible involvement in cardiac dysfunction if aberrantly expressed or deficient

Beyond the preview

Go deeper on A-kinase anchoring protein 1 (AKAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on A-kinase anchoring protein 1 (AKAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call